Document:

Exhibit 10.5

 

 

July 6th,
2017

 

	Attn:	Dr. Curt LaBelle
	Re:	Engagement Letter for Professional Services

 

Dear Dr. LaBelle:

 

On behalf of Eyenovia,
Inc. (the “Company”), I am pleased to extend our professional services agreement outlining Cura Partners engagement
as an operating Board member, Head of Operations and BD.

 

Starting July 1st,
2017, you will provide services not to exceed 2 days a week with compensation as a consultant. In this capacity, you will be paid
$9,567 per month and for any additional work at the rate of $250 per hour.

 

In addition, the Board
is approving a total of 500,000 options. 75% of the total option package will be granted now and will start vesting immediately
in thirty-six (36) equal monthly installments. The additional 25% of the options will be bestowed within 12 months and will be
based on meeting pre-specified milestones as proposed by you and approved by management.

 

As a condition of
your engagement, you will be required to sign the Company’s standard form of nondisclosure and assignment agreement (a copy
of which is enclosed), and to provide the Company with documents establishing your identity and right to work in the United States.

 

The Company may terminate
this agreement: (i) for convenience, upon one hundred twenty (120) days written notice to Consultant; or (ii) immediately for Consultant’s
failure to satisfactorily perform his/her duties described above or for Consultant’s breach of any of his/her obligations
under this agreement.

 

We look forward to working with you at the
Company. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement.

 

	 	Sincerely,
	 	 
	 	/s/
    Tsontcho Ianchulev
	 	Tsontcho
    Ianchulev, MD 
	 	CEO- Eyenovia,
    Inc.
	 	 
	 	The foregoing
    terms are hereby understood and accepted:
	 	 	 
	 	Signed:	/s/ Curt
    LaBelle

 

www.eyenoviabio.comExhibit 10.6

 

EYENOVIA, INC.

 

AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT

 

September 27, 2017

 

     

     

    

TABLE OF CONTENTS

 

	 	 	Page
	 	 	 
	Section 1 Definitions	1
	 	 	 
	1.1	Certain Definitions	1
	 	 	 
	Section 2 Registration Rights	4
	 	 	 
	2.1	Requested Registration	4
	2.2	Company Registration	6
	2.3	Registration on Form S-3	7
	2.4	Expenses of Registration	8
	2.5	Registration Procedures	8
	2.6	Indemnification	10
	2.7	Information by Holder	11
	2.8	Restrictions on Transfer	12
	2.9	Rule 144 Reporting	13
	2.10	Market Stand-Off Agreement	14
	2.11	Delay of Registration	14
	2.12	Transfer or Assignment of Registration Rights	14
	2.13	Limitations on Subsequent Registration Rights	14
	2.14	Termination of Registration Rights	14
	 	 	 
	Section 3 Covenants of the Company	15
	 	 	 
	3.1	Basic Financial Information and Inspection Rights	15
	3.2	Confidentiality	16
	3.3	Proprietary Information and Inventions Agreement	16
	3.4	Director and Officer Insurance	16
	3.5	Key Person Insurance	16
	3.6	Compliance with Laws	16
	3.7	“Bad Actor” Notice	16
	3.8	Termination of Covenants	16
	 	 	 
	Section 4 Pre-Emptive Rights	17
	 	 	 
	4.1	Pre-Emptive Rights to Significant Holders	17
	 	 	 
	Section 5 Miscellaneous	18
	 	 	 
	5.1	Amendment	18
	5.2	Notices	18
	5.3	Governing Law	19
	5.4	Successors and Assigns	19
	5.5	Entire Agreement	19
	5.6	Delays or Omissions	20
	5.7	Severability	20
	5.8	Titles and Subtitles	20
	5.9	Counterparts	20
	5.10	Electronic Execution and Delivery	20
	5.11	Jurisdiction; Venue	20
	5.12	Further Assurances	20
	5.13	Termination Upon Change of Control	21

 

    	 	-i-	 

     

    

 

TABLE OF CONTENTS

(continued)

 

	 	 	Page
	 	 	 
	5.14	Conflict	21
	5.15	Attorneys’ Fees	21
	5.16	Aggregation of Stock	21

 

    	 	-ii-	 

     

    

 

EYENOVIA, INC.

AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT

 

This Amended and
Restated Investors’ Rights Agreement (this “Agreement”) is dated as of September 27,
2017, and is between EYENOVIA, INC., a Delaware corporation (the “Company”), the holders of Series
A Preferred Stock of the Company as listed on Schedule 1 hereto (the “Series A Investors”),
the holders of Series A-2 Preferred Stock of the Company as listed on Schedule 2 hereto (the “Series A-2
Investors”) and the investors listed on Schedule 3 hereto (the “Series B
Investors” and together with the Series A Investors and the Series A-2 the
“Investors” and each an “Investor”).

 

Recitals

 

WHEREAS, the Series
A Investors and Series A-2 Investors hold shares of the Company’s Series A Preferred Stock (as defined below), Series A-2
Preferred Stock (as defined below), and/or shares of Common Stock issued upon conversion thereof and such Investors possess registration
rights, information rights, pre-emptive rights, and other rights pursuant to that certain Investor’s Rights Agreement, dated
as of March 18, 2015, between the Company and such Investors (as amended, the “Prior Agreement”);

 

WHEREAS, the Series
A Investors and the Series A-2 Investors desire to amend and restate the Prior Agreement in its entirety and to accept the rights
created pursuant to this Agreement in lieu of the rights granted to them under the Prior Agreement; and

 

WHEREAS, the Series
B Investors are parties to that certain Series B Preferred Stock Purchase Agreement of even date herewith between the Company and
such Investors (the “Purchase Agreement”), under which certain of the Company’s and the Series
B Investors’ obligations are conditioned upon the execution and delivery of this Agreement by the Series A Investors, the
Series A-2 Investors and the Company.

 

NOW, THEREFORE, the parties hereby
agree as follows:

 

Section 1

 

Definitions

 

1.1         Certain
Definitions.  As used in this Agreement, the following terms shall have the meanings set forth below:

 

(a)          “Affiliate”
shall mean, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or
is under common control with such Person, including without limitation any subsidiary, parent, general partner, limited partner,
retired partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that
is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.

 

(b)          
“Bad Actor Disqualification” means any “bad actor” disqualification described in Rule 506(d)(1)
through (viii) under the Securities Act.

 

     

     

    

 

(c)          “Commission”
shall mean the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

(d)          “Common
Stock” means the Common Stock of the Company.

 

(e)          “Conversion
Stock” shall mean shares of Common Stock issued upon conversion of the Preferred Stock.

 

(f)           “Election
Period” shall have the meaning set forth in Section 4.1(b).

 

(g)          “Excess
Shares” shall have the meaning set forth in Section 4.1(d).

 

(h)          “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the
rules and regulations thereunder, all as the same shall be in effect from time to time.

 

(i)           “Exercising
Holder” shall have the meaning set forth in Section 4.1(c).

 

(j)           “Holder”
shall mean any Investor who holds Registrable Securities and any holder of Registrable Securities to whom the registration rights
conferred by this Agreement have been duly and validly transferred in accordance with Section 2.12 of this Agreement.

 

(k)          “Indemnified
Party” shall have the meaning set forth in Section 2.6(c).

 

(l)           “Indemnifying
Party” shall have the meaning set forth in Section 2.6(c).

 

(m)         “Initial
Public Offering” shall mean the closing of the Company’s first firm commitment underwritten public offering
of the Company’s Common Stock registered under the Securities Act.

 

(n)          “Initiating
Holders” shall have the meaning set forth in Section 2.1(a).

 

(o)          “Investors”
shall mean the Series A Investors, Series A-2 Investors and Series B Investors, collectively.

 

(p)          “New
Securities” shall have the meaning set forth in Section 4.1(a).

 

(q)          “Non-Exercising
Holder” shall have the meaning set forth in Section 4.1(c).

 

(r)           “Over-allotment
Exercise Period” shall have the meaning set forth in Section 4.1(c).

 

(s)          “Over-allotment
New Securities” shall have the meaning set forth in Section 4.1(c).

 

(t)           “Person”
shall mean any individual, corporation, partnership, trust, limited liability company, association or other entity.

 

(u)          “Preferred
Stock” means, collectively, shares of the Company’s Series A Preferred Stock, Series A-2 Preferred Stock, Series
B Preferred Stock and each other series of preferred stock subsequently issued by the Company.

 

    	 	-2-	 

     

    

 

(v)          “Prior
Agreement” shall have the meaning set forth in the Recitals.

 

(w)          “Purchase
Agreement” shall have the meaning set forth in the Recitals.

 

(x)          “Registrable
Securities” shall mean (i) shares of Common Stock issued or issuable pursuant to the conversion of the Shares
and (ii) any Common Stock issued as a dividend or other distribution with respect to or in exchange for or in replacement
of the shares referenced in (i) above; provided, however, that Registrable Securities shall not include any
shares of Common Stock described in clause (i) or (ii) above which have previously been registered or which have been sold to the
public either pursuant to a registration statement or Rule 144, or which have been sold in a private transaction in which
the transferor’s rights under this Agreement are not validly assigned in accordance with this Agreement.

 

(y)          The
terms “register,” “registered” and “registration”
shall refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act and
applicable rules and regulations thereunder, and the declaration or ordering of the effectiveness of such registration statement.

 

(z)          “Registration
Expenses” shall mean all expenses incurred in effecting any registration pursuant to this Agreement, including, without
limitation, all registration, qualification, and filing fees, printing expenses, escrow fees, fees and disbursements of counsel
for the Company and one special counsel for the Holders, blue sky fees and expenses, and expenses of any regular or special audits
incident to or required by any such registration, but shall not include Selling Expenses, fees and disbursements of other counsel
for the Holders and the compensation of regular employees of the Company, which shall be paid in any event by the Company.

 

(aa)        “Restricted
Securities” shall mean any Registrable Securities required to bear the first legend set forth in Section 2.8(c).

 

(bb)       “Right
of First Refusal and Co-Sale Agreement” shall mean the Amended and Restated Right of First Refusal and Co-Sale Agreement,
dated of even date herewith, between the Company and the individuals and entities listed on Schedules 1, 2 and 3 thereto.

 

(cc)        “Rule 144”
shall mean Rule 144 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time to time,
or any similar successor rule that may be promulgated by the Commission.

 

(dd)       “Rule 145”
shall mean Rule 145 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time to time,
or any similar successor rule that may be promulgated by the Commission.

 

(ee)        “Securities Act” shall mean the Securities Act of 1933, as amended, or any similar successor federal
statute and the rules and regulations thereunder, all as the same shall be in effect from time to time.

 

(ff)         “Selling
Expenses” shall mean all underwriting discounts, selling commissions and stock transfer taxes applicable to the sale
of Registrable Securities and fees and disbursements of counsel for any Holder (other than the fees and disbursements of one special
counsel to the Holders included in Registration Expenses).

 

(gg)       “Series
A Investors” shall mean the persons and entities listed on Schedule 1.

 

    	 	-3-	 

     

    

 

(hh)       “Series
A Preferred Stock” shall mean the shares of Series A Preferred Stock of the Company, par value $0.0001 per share.

 

(ii)          “Series
A-2 Investors” shall mean the persons and entities listed on Schedule 2.

 

(jj)          “Series A-2 Preferred Stock” shall mean the shares of Series A-2 Preferred Stock of the Company, par
value $0.0001 per share.

 

(kk)        “Series
B Investors” shall mean the persons and entities listed on Schedule 3.

 

(ll)          “Series
B Preferred Stock” shall mean the shares of Series B Preferred Stock of the Company, par value $0.0001 per share.

 

(mm)      “Shares”
shall mean the Company’s Preferred Stock.

 

(nn)       “Significant
Holders” shall have the meaning set forth in Section 4.1.

 

Section 2

 

Registration Rights

 

2.1         Requested
Registration.

 

(a)          Request
for Registration. Subject to the conditions set forth in this Section 2.1, if the Company shall receive from
Holders (the “Initiating Holders”) of

 

(i)          at
least a majority of the Series B Preferred Stock, or

 

(ii)         at
least a majority of the outstanding Registrable Securities,

 

that the Company effect any
registration with respect to all or a part of the Registrable Securities (such request shall state the number of shares of Registrable
Securities to be disposed of and the intended methods of disposition of such shares by such Initiating Holders), then the Company
will (1) promptly give written notice of the proposed registration to all other Holders; and (2) as soon as practicable, file and
use its commercially reasonable efforts to effect such registration (including, without limitation, filing post-effective amendments,
appropriate qualifications under applicable blue sky or other state securities laws, and appropriate compliance with the Securities
Act) and to permit or facilitate the sale and distribution of all or such portion of such Registrable Securities as are specified
in such request, together with all or such portion of the Registrable Securities of any Holder or Holders joining in such request
as are specified in a written request received by the Company within twenty (20) days after such written notice from the Company
is mailed or delivered. In the event the registration request is made by Initiating Holders pursuant to Section 2.1(a)(i),
such request shall be limited to those Registrable Securities that would be received by such Initiating Holders upon conversion
of their Series B Preferred Stock into Common Stock, and any other shares of Common Stock held by such Initiating Holders at the
time such request is made.

 

(b)          Limitations
on Requested Registration. The Company shall not be obligated to effect, or to take any action to effect, any such registration
pursuant to this Section 2.1:

 

(i)          Prior
to the earlier of (A) the ten (10) year anniversary of the date of this Agreement or (B) one hundred eighty (180) days
following the effective date of the first registration statement filed by the Company covering an underwritten offering of any
of its securities to the general public (or the subsequent date on which all market stand-off agreements applicable to the offering
have terminated);

 

    	 	-4-	 

     

    

 

(ii)         If
the Initiating Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration
statement, propose to sell Registrable Securities and such other securities (if any) at an aggregate offering price, net of underwriters’
discounts and expenses, of less than $2.00 per share of Common Stock (as adjusted for any stock dividends, combinations or splits
with respect to such shares) and the aggregate proceeds of which (after deduction for underwriter’s discounts and expenses
related to the issuance) are less than $20,000,000;

 

(iii)        In
any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting
such registration, qualification, or compliance, unless the Company is already subject to service in such jurisdiction and except
as may be required by the Securities Act;

 

(iv)        With
respect to registration requests made by Initiating Holders pursuant to Section 2.1(a)(i), after the Company has initiated
two (2) such registrations pursuant thereto;

 

(v)         With
respect to registration requests made by Initiating Holders pursuant to Section 2.1(a)(ii), after the Company has initiated
two (2) such registrations pursuant thereto;

 

(vi)        During
the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of, and
ending on a date one hundred eighty (180) days after the effective date of, a Company-initiated registration (or ending on the
subsequent date on which all market stand-off agreements applicable to the offering have terminated); provided that the
Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective;
or

 

(vii)       If
the Initiating Holders propose to dispose of shares of Registrable Securities that may be registered on Form S-3 pursuant to a
request made under Section 2.3;

 

(viii)      If
the Initiating Holders do not request that such offering be firmly underwritten by nationally recognized underwriters selected
by the Initiating Holders (subject to the consent of the Company); or

 

(ix)        If
the Company and the Initiating Holders are unable to obtain the commitment of the underwriter described in Section 2.1(b)(vii)
above to firmly underwrite the offer.

 

(c)          Deferral.
If (i) in the good faith judgment of the board of directors of the Company, the filing of a registration statement covering
the Registrable Securities would be detrimental to the Company and the board of directors of the Company concludes, as a result,
that it is in the best interests of the Company to defer the filing of such registration statement at such time, and (ii) the
Company shall furnish to such Holders a certificate signed by the President of the Company stating that in the good faith judgment
of the board of directors of the Company, it would be detrimental to the Company for such registration statement to be filed in
the near future and that it is, therefore, in the best interests of the Company to defer the filing of such registration statement,
then (in addition to the limitations set forth in Section 2.1(b)(vi) above) the Company shall have the right to defer such
filing for a period of time to be reasonably determined by the board of directors of the Company after receipt of the request of
the Initiating Holders, and, provided further, that the Company shall not defer its obligation in this manner more than twice in
any twelve-month period.

 

    	 	-5-	 

     

    

 

(d)          Underwriting.
Unless the Registrable Securities may be registered by the Company on Form S-3, the right of any Holder to include
all or any portion of its Registrable Securities in a registration pursuant to this Section 2.1 shall be conditioned
upon such Holder’s participation in an underwriting and the inclusion of such Holder’s Registrable Securities to the
extent provided herein. If the Company shall request inclusion in any registration pursuant to Section 2.1 of securities
being sold for its own account, or if other persons shall request inclusion in any registration pursuant to Section 2.1,
the Initiating Holders shall, on behalf of all Holders, offer to include such securities in the underwriting and such offer shall
be conditioned upon the participation of the Company or such other persons in such underwriting and the inclusion of the Company’s
and such person’s other securities of the Company and their acceptance of the further applicable provisions of this Section 2
(including Section 2.10). The Company shall (together with all Holders proposing to distribute their securities through
such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or underwriters
selected for such underwriting by the Company, which underwriters are reasonably acceptable to the holders of a majority of the
Registrable Securities (determined on an as-converted basis) then held by the Initiating Holders.

 

Notwithstanding any other
provision of this Section 2.1, if the underwriters advise the Initiating Holders in writing that marketing factors
require a limitation on the number of shares to be underwritten, the number of Registrable Securities that may be so included shall
be allocated as follows: (i) first, among all Holders requesting to include Registrable Securities in such registration statement
based on the pro rata percentage of Registrable Securities held by such Holders, assuming conversion; (ii) second, to the
Company, which the Company may allocate, at its discretion, for its own account, or for the account of other holders or employees
of the Company.

 

If a person who has requested
inclusion in such registration as provided above does not agree to the terms of any such underwriting, such person shall be excluded
therefrom by written notice from the Company, the underwriter or the Initiating Holders. The securities so excluded shall also
be withdrawn from registration. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall
also be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares to be included
in such registration was previously reduced as a result of marketing factors pursuant to this Section 2.1(d), then
the Company shall then offer to all Holders who have retained rights to include securities in the registration the right to include
additional Registrable Securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such
shares to be allocated among such Holders requesting additional inclusion, as set forth above.

 

2.2         Company
Registration.

 

(a)          Company
Registration. If the Company shall determine to register any of its securities either for its own account or the account
of a security holder or holders, other than a registration pursuant to Section 2.1 or 2.3, a registration relating
solely to employee benefit plans, a registration relating to the offer and sale of debt securities, a registration relating to
a corporate reorganization or other Rule 145 transaction, or a registration on any registration form that does not permit secondary
sales, the Company will:

 

(i)          promptly
give written notice of the proposed registration to all Holders; and

 

(ii)         use
its commercially reasonable efforts to include in such registration (and any related qualification under blue sky laws or other
compliance), except as set forth in Section 2.2(b) below, and in any underwriting involved therein, all of such Registrable
Securities as are specified in a written request or requests made by any Holder or Holders received by the Company within ten (10)
days after such written notice from the Company is mailed or delivered. Such written request may specify all or a part of a Holder’s
Registrable Securities.

 

    	 	-6-	 

     

    

 

(b)          Underwriting.
If the registration of which the Company gives notice is for a registered public offering involving an underwriting, the Company
shall so advise the Holders as a part of the written notice given pursuant to Section 2.2(a)(i). In such event, the
right of any Holder to registration pursuant to this Section 2.2 shall be conditioned upon such Holder’s participation
in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided
herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company and the
other holders of securities of the Company with registration rights to participate therein distributing their securities through
such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or underwriters
selected by the Company.

 

Notwithstanding any other
provision of this Section 2.2, if the underwriters advise the Company in writing that marketing factors require a limitation
on the number of shares to be underwritten, the underwriters may (subject to the limitations set forth below) limit the number
of Registrable Securities to be included in, the registration and underwriting. The Company shall so advise all holders of securities
requesting registration, and the number of shares of securities that are entitled to be included in the registration and underwriting
shall be allocated, as follows: (i) first, to the Company for securities being sold for its own account, and (ii) second, to the
Holders requesting to include Registrable Securities in such registration statement based on the pro rata percentage of
Registrable Securities held by such Holders, assuming conversion.

 

If a person who has requested
inclusion in such registration as provided above does not agree to the terms of any such underwriting, such person shall also be
excluded therefrom by written notice from the Company or the underwriter. The Registrable Securities or other securities so excluded
shall also be withdrawn from such registration. Any Registrable Securities or other securities excluded or withdrawn from such
underwriting shall be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares
of Registrable Securities to be included in such registration was previously reduced as a result of marketing factors pursuant
to Section 2.2(b), the Company shall then offer to all persons who have retained the right to include securities in
the registration the right to include additional securities in the registration in an aggregate amount equal to the number of shares
so withdrawn, with such shares to be allocated among the persons requesting additional inclusion, in the manner set forth above.

 

(c)          Right
to Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under
this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities
in such registration.

 

2.3         Registration
on Form S-3.  

 

(a)          Request
for Form S-3 Registration. After its initial public offering, the Company shall use its commercially reasonable efforts
to qualify for registration on Form S-3 or any comparable or successor form or forms. After the Company has qualified for the use
of Form S-3, in addition to the rights contained in the foregoing provisions of this Section 2 and subject to the conditions
set forth in this Section 2.3, if the Company shall receive from a Holder or Holders of Registrable Securities a written
request that the Company effect any registration on Form S-3 or any similar short form registration statement with respect to all
or part of the Registrable Securities (such request shall state the number of shares of Registrable Securities to be disposed of
and the intended methods of disposition of such shares by such Holder or Holders), the Company will take all such action with respect
to such Registrable Securities as required by Section 2.1(a)(1) and Section 2.1(a)(2).

 

    	 	-7-	 

     

    

 

(b)          Limitations
on Form S-3 Registration. The Company shall not be obligated to effect, or take any action to effect, any such registration
pursuant to this Section 2.3:

 

(i)          In
the circumstances described in either Sections 2.1(b)(i), 2.1(b)(iii) or 2.1(b)(v); or

 

(ii)         If
the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose
to sell Registrable Securities and such other securities (if any) on Form S-3 at an aggregate price to the public of less than
$l,000,000.

 

(c)          Deferral.
The provisions of Section 2.1(c) shall apply to any registration pursuant to this Section 2.3.

 

(d)          Underwriting.
If the Holders of Registrable Securities requesting registration under this Section 2.3 intend to distribute the Registrable
Securities covered by their request by means of an underwriting, the provisions of Section 2.1(d) shall apply to such
registration. Notwithstanding anything contained herein to the contrary, registrations effected pursuant to this Section 2.3
shall not be counted as requests for registration or registrations effected pursuant to Section 2.1.

 

2.4         Expenses
of Registration.  All Registration Expenses incurred in connection with registrations pursuant to Sections 2.1,
2.2 and 2.3 shall be borne by the Company; provided, however, that the Company shall not be required
to pay for any expenses of any registration proceeding begun pursuant to Sections 2.1 and 2.3 if the registration
request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered or
because a sufficient number of Holders shall have withdrawn so that the minimum offering conditions set forth in Sections 2.1
and 2.3 are no longer satisfied (in which case all participating Holders shall bear such expenses pro rata among
each other based on the number of Registrable Securities requested to be so registered), unless the Holders of a majority of the
Registrable Securities agree to forfeit their right to one (1) demand registration pursuant to Section 2.1; provided,
however, in the event that a withdrawal by the Holders is based upon material adverse information relating to the Company
that is different from the information known or available (upon request from the Company or otherwise) to the Holders requesting
registration at the time of their request for registration under Section 2.1, such registration shall not be treated
as a counted registration for purposes of Section 2.1, even though the Holders do not bear the Registration Expenses
for such registration. All Selling Expenses relating to securities registered on behalf of the Holders shall be borne by the holders
of securities included in such registration pro rata among each other on the basis of the number of Registrable Securities
so registered.

 

2.5         Registration
Procedures.  In the case of each registration effected by the Company pursuant to Section 2, the Company will
keep each Holder advised in writing as to the initiation of each registration and as to the completion thereof. At its expense,
the Company will use its commercially reasonable efforts to:

 

(a)          Keep
such registration effective for a period ending on the earlier of the date which is sixty (60) days from the effective date of
the registration statement or such time as the Holder or Holders have completed the distribution described in the registration
statement relating thereto;

 

(b)          Prepare
and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement for the period set forth in subsection (a) above;

 

    	 	-8-	 

     

    

 

(c)          Furnish
such number of prospectuses, including any preliminary prospectuses, and other documents incident thereto, including any amendment
of or supplement to the prospectus, as a Holder from time to time may reasonably request;

 

(d)          Use
its reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities
or Blue Sky laws of such jurisdiction as shall be reasonably requested by the Holders; provided, that the Company shall
not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service
of process in any such states or jurisdictions;

 

(e)          Notify
each seller of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in
such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances
then existing, and following such notification promptly prepare and furnish to such seller a reasonable number of copies of a supplement
to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such
prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing;

 

(f)          If
at any time when the Company is required to re-evaluate its status as a well-known seasoned issuer (as defined in Rule 405 under
the Securities Act) (a “WKSI”) for purposes of an automatic shelf registration statement used to effect
a request for registration in accordance with Section 2.3 (i) the Company determines that it is not a WKSI, (ii) the registration
statement is required to be kept effective in accordance with this Agreement, and (iii) the registration rights of the applicable
Holders have not terminated, promptly amend the registration statement onto a form the Company is then eligible to use or file
a new registration statement on such form, and keep such registration statement effective in accordance with the requirements otherwise
applicable under this Agreement;

 

(g)          Provide
a transfer agent and registrar for all Registrable Securities registered pursuant to such registration statement and a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration;

 

(h)          Cause
all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed; and

 

(i)          In
connection with any underwritten offering pursuant to a registration statement filed pursuant to Section 2.1, enter
into an underwriting agreement in form reasonably necessary to effect the offer and sale of Common Stock, provided such underwriting
agreement contains reasonable and customary provisions, and provided further, that each Holder participating in such underwriting
shall also enter into and perform its obligations under such an agreement.

 

    	 	-9-	 

     

    

 

2.6         Indemnification. 

 

(a)          To
the extent permitted by law, the Company will indemnify and hold harmless each Holder, each of its officers, directors and partners,
legal counsel and accountants and each person controlling such Holder within the meaning of Section 15 of the Securities Act,
with respect to which registration, qualification or compliance has been effected pursuant to this Section 2, and each underwriter,
if any, and each person who controls within the meaning of Section 15 of the Securities Act any underwriter, against all expenses,
claims, losses, damages and liabilities (or actions, proceedings or settlements in respect thereof) arising out of or based on:
(i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any registration
statement, any prospectus included in the registration statement, any issuer free writing prospectus (as defined in Rule 433 of
the Securities Act), any issuer information (as defined in Rule 433 of the Securities Act) filed or required to be filed pursuant
to Rule 433(d) under the Securities Act or any other document incident to any such registration, qualification or compliance prepared
by or on behalf of the Company or used or referred to by the Company, (ii) any omission (or alleged omission) to state therein
a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation
(or alleged violation) by the Company of the Securities Act, any state securities laws or any rule or regulation thereunder applicable
to the Company and relating to action or inaction required of the Company in connection with any offering covered by such registration,
qualification or compliance, and the Company will reimburse each such Holder, each of its officers, directors, partners, legal
counsel and accountants and each person controlling such Holder, each such underwriter and each person who controls any such underwriter,
for any legal and any other expenses reasonably incurred in connection with investigating and defending or settling any such claim,
loss, damage, liability or action; provided that the Company will not be liable in any such case to the extent that any
such claim, loss, damage, liability, or action arises out of or is based on any untrue statement or omission based upon written
information furnished to the Company by such Holder, any of such Holder’s officers, directors, partners, legal counsel or
accountants, any person controlling such Holder, such underwriter or any person who controls any such underwriter, and stated to
be specifically for use therein; and provided, further that, the indemnity agreement contained in this Section 2.6(a)
shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected
without the consent of the Company (which consent shall not be unreasonably withheld).

 

(b)          To
the extent permitted by law, each Holder will, if Registrable Securities held by such Holder are included in the securities as
to which such registration, qualification or compliance is being effected, indemnify and hold harmless the Company, each of its
directors, officers, partners, legal counsel and accountants and each underwriter, if any, of the Company’s securities covered
by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15
of the Securities Act, each other such Holder, and each of their officers, directors and partners, and each person controlling
each other such Holder, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based
on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any
prospectus, offering circular or other document (including any related registration statement, notification, or the like) incident
to any such registration, qualification or compliance, or (ii) any omission (or alleged omission) to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company and
such Holders, directors, officers, partners, legal counsel and accountants, persons, underwriters, or control persons for any legal
or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability
or action, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission
(or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon
and in conformity with written information furnished to the Company by such Holder and stated to be specifically for use therein;
provided, however, that the obligations of such Holder hereunder shall not apply to amounts paid in settlement of
any such claims, losses, damages or liabilities (or actions in respect thereof) if such settlement is effected without the consent
of such Holder (which consent shall not be unreasonably withheld); and provided that in no event shall any indemnity under
this Section 2.6 exceed the gross proceeds from the offering received by such Holder, except in the case of fraud or
willful misconduct by such Holder.

 

    	 	-10-	 

     

    

 

(c)          Each
party entitled to indemnification under this Section 2.6 (the “Indemnified Party”) shall
give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after
such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying
Party to assume the defense of such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying
Party, who shall conduct the defense of such claim or any litigation resulting therefrom, shall be approved by the Indemnified
Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may participate in such defense at such party’s
expense; and provided further that the failure of any Indemnified Party to give notice as provided herein shall not relieve
the Indemnifying Party of its obligations under this Section 2.6, to the extent such failure is not prejudicial. No
Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent
to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the
claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. Each Indemnified
Party shall furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably request
in writing and as shall be reasonably required in connection with defense of such claim and litigation resulting therefrom.

 

(d)          If
the indemnification provided for in this Section 2.6 is held by a court of competent jurisdiction to be unavailable
to an Indemnified Party with respect to any loss, liability, claim, damage, or expense referred to herein, then the Indemnifying
Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified
Party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative
fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or
omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations.
The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information
supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information,
and opportunity to correct or prevent such statement or omission. No person or entity will be required under this Section 2.6(d)
to contribute any amount in excess of the gross proceeds from the offering received by such person or entity, except in the case
of fraud or willful misconduct by such person or entity. No person or entity guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty
of such fraudulent misrepresentation.

 

(e)          Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

 

2.7         Information
by Holder.  Each Holder of Registrable Securities shall furnish to the Company such information regarding such Holder
and the distribution proposed by such Holder as the Company may reasonably request in writing and as shall be reasonably required
in connection with any registration, qualification, or compliance referred to in this Section 2.

 

    	 	-11-	 

     

    

 

2.8           Restrictions
on Transfer.

 

(a)          The
holder of each certificate representing Registrable Securities by acceptance thereof agrees to comply in all respects with the
provisions of this Section 2.8. Each Holder agrees not to make any sale, assignment, transfer, pledge or other disposition
of all or any portion of the Restricted Securities, or any beneficial interest therein, unless and until the transferee thereof
has agreed in writing for the benefit of the Company to take and hold such Restricted Securities subject to, and to be bound by,
the terms and conditions set forth in this Agreement, including, without limitation, this Section 2.8 and Section 2.10,
and:

 

(i)          There
is then in effect a registration statement under the Securities Act covering such proposed disposition and the disposition is made
in accordance with the registration statement; or

 

(ii)         The
Holder shall have given prior written notice to the Company of the Holder’s intention to make such disposition and shall
have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, and, the Holder
shall have furnished the Company, at the Holder’s expense, with (i) an opinion of counsel reasonably satisfactory to
the Company to the effect that such disposition will not require registration of such Restricted Securities under the Securities
Act or (ii) a “no action” letter from the Commission to the effect that the transfer of such securities without
registration will not result in a recommendation by the staff of the Commission that action be taken with respect thereto, whereupon
the holder of such Restricted Securities shall be entitled to transfer such Restricted Securities in accordance with the terms
of the notice delivered by the Holder to the Company.

 

(b)          Notwithstanding
the provisions of Section 2.8(a), no such registration statement or opinion of counsel or “no action” letter
shall be necessary for (i) a transfer not involving a change in beneficial ownership, or (ii) transactions involving
the distribution without consideration of Restricted Securities by any Holder to (x) a parent, subsidiary or other affiliate
of the Holder, if the Holder is a corporation, (y) any of the Holder’s partners, members or other equity owners, or
retired partners, retired members or other equity owners, or to the estate of any of the Holder’s partners, members or other
equity owners or retired partners, retired members or other equity owners, or (z) a venture capital fund that is controlled
by or under common control with one or more general partners or managing members of, or shares the same management company with,
the Holder; provided, in each case, that the Holder shall give written notice to the Company of the Holder’s intention
to effect such disposition and shall have furnished the Company with a detailed description of the manner and circumstances of
the proposed disposition.

 

(c)          Each
certificate representing Registrable Securities shall (unless otherwise permitted by the provisions of this Agreement) be stamped
or otherwise imprinted with a legend substantially similar to the following (in addition to any legend required under applicable
state securities laws):

 

THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER
THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED
EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. THE
ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER,
PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

    	 	-12-	 

     

    

 

THE SHARES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT OF A PUBLIC
OFFERING, AS SET FORTH IN AN INVESTORS’ RIGHTS AGREEMENT AMONG THE COMPANY AND THE ORIGINAL HOLDERS OF THESE SHARES, A COPY
OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE COMPANY.

 

The Holders consent to
the Company making a notation on its records and giving instructions to any transfer agent of the Restricted Securities in order
to implement the restrictions on transfer established in this Section 2.8.

 

(d)          The
first legend referring to federal and state securities laws identified in Section 2.8(c) stamped on a certificate evidencing
the Restricted Securities and the stock transfer instructions and record notations with respect to the Restricted Securities shall
be removed and the Company shall issue a certificate without such legend to the holder of Restricted Securities if (i) those
securities are registered under the Securities Act, or (ii) the holder provides the Company with an opinion of counsel reasonably
acceptable to the Company to the effect that a sale or transfer of those securities may be made without registration or qualification.

 

(e)          Each
Investor agrees not to make any sale, assignment, transfer, pledge or other disposition of any securities of the Company, or any
beneficial interest therein, to any person other than the Company unless and until the proposed transferee confirms to the reasonable
satisfaction of the Company that neither the proposed transferee nor any of its directors, executive officers, other officers that
may serve as a director or officer of any company in which it invests, general partners or managing members nor any person that
would be deemed a beneficial owner of those securities (in accordance with Rule 506(d) of the Securities Act) is subject to any
Bad Actor Disqualification, except as set forth in Rule 506(d)(2) or (d)(3) under the Securities Act and disclosed, reasonably
in advance of the transfer, in writing in reasonable detail to the Company.

 

2.9         Rule 144
Reporting.  With a view to making available the benefits of certain rules and regulations of the Commission that may permit
the sale of the Restricted Securities to the public without registration, the Company agrees to use its commercially reasonable
efforts to:

 

(a)          Make
and keep adequate current public information with respect to the Company available in accordance with Rule 144 under the Securities
Act, at all times from and after ninety (90) days following the effective date of the first registration under the Securities Act
filed by the Company for an offering of its securities to the general public;

 

(b)          File
with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the
Exchange Act at any time after it has become subject to such reporting requirements; and

 

(c)          So
long as a Holder owns any Restricted Securities, furnish to the Holder forthwith upon written request a written statement by the
Company as to its compliance with the reporting requirements of Rule 144 (at any time from and after ninety (90) days following
the effective date of the first registration statement filed by the Company for an offering of its securities to the general public),
and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), a copy
of the most recent annual or quarterly report of the Company, and such other reports and documents so filed as a Holder may reasonably
request in availing itself of any rule or regulation of the Commission allowing a Holder to sell any such securities without registration.

 

    	 	-13-	 

     

    

 

2.10       Market
Stand-Off Agreement.  Each Holder shall not sell or otherwise transfer, make any short sale of, grant any option for the
purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, of any Common Stock (or
other securities) of the Company held by such Holder (other than those included in the registration) during the one hundred eighty
(180) day period following the effective date of the registration statement for the Company’s Initial Public Offering filed
under the Securities Act (or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions
on (i) the publication or other distribution of research reports and (ii) analyst recommendations and opinions, including,
but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions
or amendments thereto), provided that all officers and directors and holders of at least one percent (1%) of the Company’s
voting securities are bound by and have entered into similar agreements. The obligations described in this Section 2.10 shall
not apply to a registration relating solely to employee benefit plans on Form S-l or Form S-8 or similar forms that may be promulgated
in the future, or a registration relating solely to a transaction on Form S-4 or similar forms that may be promulgated in the future.
The Company may impose stop-transfer instructions and may stamp each such certificate with the second legend set forth in Section 2.8(c)
with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of such restricted
period. Each Holder agrees to execute a market standoff agreement with said underwriters in customary form consistent with the
provisions of this Section 2.10.

 

2.11       Delay
of Registration.  No Holder shall have any right to take any action to restrain, enjoin, or otherwise delay any registration
as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2.

 

2.12       Transfer
or Assignment of Registration Rights.  The rights to cause the Company to register securities granted to a Holder by the
Company under this Section 2 may be transferred or assigned (but only with all related obligations) by (a) any Holder
that is an entity to its Affiliate or (b) by a Holder to a transferee or assignee of such securities who, after such assignment
or transfer, holds at least 300,000 shares of Registrable Securities (as presently constituted and subject to subsequent adjustments
for stock splits, stock dividends, reverse stock splits, and the like); provided that (i) such transfer or assignment
of Registrable Securities is effected in accordance with the terms of Section 2.8, the Right of First Refusal and Co-Sale
Agreement, and applicable securities laws, (ii) the Company is given written notice prior to said transfer or assignment,
stating the name and address of the transferee or assignee and identifying the securities with respect to which such registration
rights are intended to be transferred or assigned and (iii) the transferee or assignee of such rights assumes in writing the
obligations of such Holder under this Agreement, including without limitation the obligations set forth in Section 2.10.

 

2.13       Limitations
on Subsequent Registration Rights.  From and after the date of this Agreement, the Company shall not, without the prior
written consent of Holders holding at least a majority of the Registrable Securities (excluding any of such shares held by any
Holders whose rights to request registration or inclusion in any registration pursuant to this Section 2 have terminated
in accordance with Section 2.14), enter into any agreement with any holder or prospective holder of any securities
of the Company giving such holder or prospective holder any registration rights the terms of which are pari passu with or senior
to the registration rights granted to the Holders hereunder.

 

2.14       Termination
of Registration Rights.  The right of any Holder to request registration or inclusion in any registration pursuant to
Sections 2.1, 2.2 or 2.3 shall terminate on the earlier of (i) such date, on or after the closing
of the Company’s Initial Public Offering of Common Stock, on which all shares of Registrable Securities held or entitled
to be held upon conversion by such Holder may immediately be sold under Rule 144 during any ninety (90) day period, and (ii) three
(3) years after the closing of the Company’s Initial Public Offering.

 

    	 	-14-	 

     

    

 

Section 3

 

Covenants
of the Company

 

The Company hereby covenants
and agrees, as follows:

 

3.1         Basic
Financial Information and Inspection Rights.

 

(a)          Basic
Financial Information. The Company will furnish the following reports to each Investor who owns at least 300,000 Shares
and/or Conversion Stock (as presently constituted and subject to subsequent adjustments for stock splits, stock dividends, reverse
stock splits, and the like):

 

(i)          As
soon as practicable after the end of each fiscal year of the Company, and in any event within one hundred twenty (120) days after
the end of each fiscal year of the Company, a consolidated balance sheet of the Company and its subsidiaries, if any, as at the
end of such fiscal year, and consolidated statements of income and cash flows of the Company and its subsidiaries, if any, for
such year, prepared in accordance with U.S. generally accepted accounting principles consistently applied, certified by independent
public accountants of recognized national standing selected by the Company.

 

(ii)         As
soon as practicable after the end of the first, second and third quarterly accounting periods in each fiscal year of the Company,
and in any event within thirty (30) days after the end of the first, second, and third quarterly accounting periods in each fiscal
year of the Company, an unaudited consolidated balance sheet of the Company and its subsidiaries, if any, as of the end of each
such quarterly period, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries, if any,
for such period, prepared in accordance with U.S. generally accepted accounting principles consistently applied, subject to changes
resulting from normal year-end audit adjustments.

 

(iii)        As
soon as practicable after the end of the third quarterly accounting period in each fiscal year of the Company, and in any event
within thirty (30) days prior to the beginning of each fiscal year of the Company, a copy of the Company’s annual operating
plan.

 

(b)          Inspection
Rights. The Company will afford each Significant Holder and each Significant Holder’s accountants and counsel reasonable
access during normal business hours to all of the Company’s respective properties, books and records. Each Significant Holder
shall have such other access to management and information as is necessary for it to comply with applicable laws and regulations
and regulations and reporting obligations. The Company shall not be required to disclose details of contracts with or work performed
for specific customers and other business partners where to do so would violate confidentiality obligations to those parties. Investors
may exercise their rights under this Section 3.1(b) only for purposes reasonably related to their interests under this Agreement
and related agreements. The rights granted pursuant to this Section 3.1(b) may not be assigned or otherwise conveyed by
the Investors or by any subsequent transferee of any such rights if the Company reasonably and in good faith determines that the
proposed transferee is a competitor of the Company, or an officer, employee, director or holder of more than ten percent (10%)
of the outstanding voting securities of such a competitor of the Company (it being understood that any Holder that is a venture
capital investor shall not be deemed by the Company to be a competitor of the Company merely by virtue of entering into any business,
entering into any agreement with a third party, or investing in or engaging in investment discussions with any other company).
Notwithstanding the foregoing, the Company shall not be obligated under this Section 3.1(b) to provide access to any properties,
books, records or other information (i) that the Company reasonably determines in good faith to be a trade secret or confidential
information (unless covered by an enforceable confidentiality agreement, in a form reasonably acceptable to the Company); or (ii)
the disclosure of or access to which would adversely affect the attorney-client privilege between the Company and its counsel.

 

    	 	-15-	 

     

    

 

3.2         Confidentiality. 
Anything in this Agreement to the contrary notwithstanding, no Holder by reason of this Agreement shall have access to any trade
secrets or classified information of the Company. The Company shall not be required to comply with any information rights of Section 3
in respect of any Holder whom the Company reasonably determines to be a competitor or an officer, employee, director or holder
of more than ten percent (10%) of a competitor. Each Holder acknowledges that the information received by them pursuant to this
Agreement may be confidential and for its use only, and it will not use such confidential information in violation of the Exchange
Act or reproduce, disclose or disseminate such information to any other person (other than its employees or agents having a need
to know the contents of such information, and its attorneys), except in connection with the exercise of rights under this Agreement,
unless the Company has made such information available to the public generally.

 

3.3         Proprietary
Information and Inventions Agreement. The Company shall require all employees and consultants to execute and deliver a Proprietary
Information and Inventions Agreement substantially in a form approved by the Company’s Board of Directors.

 

3.4         Director
and Officer Insurance.  The Company shall obtain, within ninety (90) days of the date hereof, from financially sound and
reputable insurers, and subsequently maintain in full force and effect, director and officer liability insurance in the average
amount of at least $3,000,000, until such time as the Board of Directors (including each Preferred Director) determines that such
insurance should be discontinued. For the avoidance of doubt, the foregoing covenant shall be in addition to any obligations set
forth in indemnification agreements with the Company’s directors.

 

3.5         Key
Person Insurance.  The Company shall obtain, if it does
not already possess, within ninety (90) days of the date hereof, and subsequently maintain in full force and effect, key person
insurance in the amount of $1,000,000 for the following individual: Curt LaBelle.

 

3.6         Compliance
with Laws; Maintenance of Intellectual Property.  The Company shall use its best efforts to comply with all laws, including
ERISA. The Company shall take commercially reasonable efforts to maintain the validity of each patent, trademark registration,
patent or trademark application and other registered intellectual property, to the extent the same were valid at the time the Company
acquired them, unless the Company in its ordinary business judgment elects to abandon, discontinue prosecution or maintenance of
, disclaim or dedicate such intellectual property to the public domain.

 

3.7         “Bad
Actor” Notice.  Each party to this Agreement will promptly notify each other party to this Agreement in writing
if it or, to its knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any Bad Actor Disqualification.

 

3.8         Termination
of Covenants.  The covenants set forth in this Section 3 shall terminate and be of no further force and effect after
the closing of the Company’s Initial Public Offering; provided, however, that the holders of the Shares shall
be entitled to receive the same reports and other information that the Company provides to the holders of its Common Stock.

 

    	 	-16-	 

     

    

 

Section 4

 

Pre-Emptive
Rights

 

4.1         Pre-Emptive
Rights to Significant Holders.  The Company hereby grants (i) to each Holder who owns at least 300,000 Shares or Conversion
Stock (as presently constituted and subject to subsequent adjustments for stock splits, stock dividends, reverse stock splits and
the like) and (ii) to each Holder of Series B Preferred Stock (each, a “Significant Holder” and collectively,
the “Significant Holders”), the pre-emptive right to purchase its Pre-Emptive Pro Rata Share of New Securities
(as defined in this Section 4.1(a)) which the Company may, from time to time, propose to sell and issue after the date
of this Agreement. A Significant Holder’s Pre-Emptive Pro Rata Share, for purposes of this pre-emptive right,
is equal to the ratio of (a) the number of shares of Common Stock owned by such Significant Holder immediately prior to the issuance
of New Securities (assuming full conversion of the Shares and full conversion or exercise of all outstanding convertible securities,
rights, options and warrants held by said Significant Holder) to (b) the total number of shares of Common Stock outstanding immediately
prior to the issuance of New Securities (assuming full conversion of the Shares and full conversion or exercise of all outstanding
convertible securities, rights, options and warrants).

 

(a)          “New
Securities” shall mean any capital stock (including Common Stock and/or Preferred Stock) of the Company whether now
authorized or not, and rights, convertible securities, options or warrants to purchase such capital stock, and securities of any
type whatsoever that are, or may become, exercisable or convertible into capital stock; provided that the term “New
Securities” does not include any securities excluded from the definition of “Additional Shares of Common”
or “Excluded Securities” under the Company’s certificate of incorporation, as amended from time to time.

 

(b)          In
the event the Company proposes to undertake an issuance of New Securities, it shall give each Significant Holder written notice
of its intention, describing the type of New Securities, and their price and the general terms upon which the Company proposes
to issue the same. Each Significant Holder shall have ten (10) days after any such notice is mailed or delivered (the “Election
Period”) to agree to purchase such Holder’s pro rata share of such New Securities for the price and
upon the terms specified in the notice by giving written notice to the Company, in substantially the form attached as Exhibit A,
and stating therein the quantity of New Securities to be purchased.

 

(c)          Each
Significant Holder exercising its right to purchase its Pre-emptive Pro Rata Share of the New Securities in full (an “Exercising
Holder”) shall have a right of over-allotment such that if any other Significant Holder fails to exercise its right
under this Section 4.1 to purchase its Pre-emptive Pro Rata Share of the New Securities (each, a “Non-Exercising
Holder”), such Exercising Holder may purchase all or any portion of such Non-Exercising Holder’s allotment
(the “Over-allotment New Securities”) by giving written notice to the Company setting forth the number
of Over-allotment New Securities that such Exercising Holder is willing to purchase within five (5) days of receipt of the Over-allotment
Notice (the “Over-allotment Exercise Period”). Such Exercising Holder’s election to purchase Over-allotment
New Securities shall be binding and irrevocable. If more than one Exercising Holder elects to exercise its right of over-allotment,
each Exercising Holder shall have the right to purchase the number of Over-allotment New Securities it elected to purchase in its
written notice; provided, that if the over-allotment New Securities are over-subscribed, each Exercising Holder shall purchase
its pro rata portion of the available Over-allotment New Securities based upon the relative Pre-emptive Pro Rata Shares of the
Exercising Holders

 

    	 	-17-	 

     

    

 

(d)          In
the event the Significant Holders fail to exercise fully their pre-emptive rights and over-allotment rights, if any, following
the expiration of the applicable Election Period and Over-allotment Exercise Period, the Company shall have ninety (90) days thereafter
to sell or enter into an agreement pursuant to which the sale of New Securities covered thereby shall be closed, if at all, within
ninety (90) days from the date of said agreement to sell that portion of the New Securities with respect to which the Significant
Holders’ pre-emptive rights set forth in this Section 4.1 was not exercised (the “Excess Shares”),
at a price and upon terms no more favorable to the purchasers thereof than specified in the Company’s notice to Significant
Holders delivered pursuant to Section 4.1(b). In the event the Company has not sold the Excess Shares within such ninety
(90) day period following the Election Period, or such ninety (90) day period following the date of said agreement, the Company
shall not thereafter issue or sell any New Securities, without first again offering the Excess Shares to the Significant Holders
in the manner provided in this Section 4.1.

 

(e)          The
pre-emptive rights granted under this Agreement shall expire upon, and shall not be applicable to, the Company’s Initial
Public Offering.

 

(f)          A
Holder will not have any pre-emptive rights to purchase a pro rata share of New Securities in accordance with this Section
4.1 and will not be a Significant Holder for purposes of pre-emptive rights granted under this Section 4.1 if, and for
so long as, the Holder, any of its directors, executive officers, other officers that may serve as a director or officer of any
company in which it invests, general partners or managing members or any person that would be deemed a beneficial owner of the
securities of the Company held by the Holder (in accordance with Rule 506(d) of the Securities Act) is subject to any Bad Actor
Disqualification, except as set forth in Rule 506(d)(2) or (d)(3) under the Securities Act.

 

Section 5

 

Miscellaneous

 

5.1         Amendment. 
Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated
other than by a written instrument referencing this Agreement and signed by the Company and the Holders holding a majority of the
Registrable Securities (excluding any of such shares that have been sold to the public or pursuant to Rule 144, and excluding,
with respect to Section 2 (other than Sections 2.8, 2.9 and 2.10), any of such shares held
by any Holders whose rights to request registration or inclusion in any registration pursuant to Section 2 have terminated
in accordance with Section 2.14); provided, however, that if any amendment, waiver, discharge or termination
operates in a manner that treats any Holder different from other Holders, the consent of such Holder shall also be required for
such amendment, waiver, discharge or termination. Any such amendment, waiver, discharge or termination effected in accordance with
this paragraph shall be binding upon each Holder and each future holder of all such securities of Holder. Each Holder acknowledges
that by the operation of this paragraph, the holders of a majority of the Registrable Securities (excluding any of such shares
that have been sold to the public or pursuant to Rule 144, and excluding, with respect to Section 2 (other than
Sections 2.8, 2.9 and 2.10), any of such shares held by any Holders whose rights to request registration
or inclusion in any registration pursuant to Section 2 have terminated in accordance with Section 2.14)
will have the right and power to diminish or eliminate all rights of such Holder under this Agreement.

 

5.2         Notices. 
All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified
mail, postage prepaid, sent by facsimile or electronic mail or otherwise delivered by hand, messenger or courier service addressed:

 

(a)          if
to an Investor, to the Investor’s address, facsimile number or electronic mail address as shown in the Company’s records,
as may be updated in accordance with the provisions hereof.

 

    	 	-18-	 

     

    

 

(b)          if
to any Holder, to such address, facsimile number or electronic mail address as shown in the Company’s records, or, until
any such Holder so furnishes an address, facsimile number or electronic mail address to the Company, then to the address of the
last holder of such shares for which the Company has contact information in its records; or

 

(c)          if
to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 315 Montgomery Street,
Suite 100, San Francisco, CA 94104, or at such other current address as the Company shall have furnished to the Investors or Holders,
with a copy (which shall not constitute notice) to Hill Ward Henderson, 101 East Kennedy Boulevard, Suite 3700, Tampa, Florida
33602, Attention: R. Reid Haney.

 

Each such notice or other
communication shall for all purposes of this Agreement be treated as effective or having been given (i) if delivered by hand,
messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service, freight prepaid,
specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent via mail, at the
earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for the deposit of the
United States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer
or, (iv) if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent
during normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s
next business day.

 

Subject to the limitations
set forth in Delaware General Corporation Law §232(e), each Investor and Holder consents to the delivery of any notice to
stockholders given by the Company under the Delaware General Corporation Law or the Company’s certificate of incorporation
or bylaws by (i) facsimile telecommunication to the facsimile number set forth on Exhibit A (or to any other facsimile
number for the Investor or Holder in the Company’s records), (ii) electronic mail to the electronic mail address set
forth on Exhibit A (or to any other electronic mail address for the Investor or Holder in the Company’s records), (iii) posting
on an electronic network together with separate notice to the Investor or Holder of such specific posting or (iv) any other
form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the Investor or Holder. This consent
may be revoked by an Investor or Holder by written notice to the Company and may be deemed revoked in the circumstances specified
in Delaware General Corporation Law §232.

 

5.3         Governing
Law.  This Agreement shall be governed in all respects by the internal laws of the State of Delaware, without regard to
principles of conflicts of law.

 

5.4         Successors
and Assigns.  This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred,
delegated or sublicensed by any Investor without the prior written consent of the Company. Any attempt by an Investor without such
permission to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement shall
be void. Subject to the foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure to the
benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

5.5         Entire
Agreement.  This Agreement and the exhibits hereto constitute the full and entire understanding and agreement between
the parties with regard to the subjects hereof. No party hereto shall be liable or bound to any other party in any manner with
regard to the subjects hereof or thereof by any warranties, representations or covenants except as specifically set forth herein.

 

    	 	-19-	 

     

    

 

5.6         Delays
or Omissions.  Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing
to any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right,
power or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of
any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any
party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically
set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement,
shall be cumulative and not alternative.

 

5.7         Severability. 
If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or
void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement,
and such court will replace such illegal, void or unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable
provision. The balance of this Agreement shall be enforceable in accordance with its terms.

 

5.8         Titles
and Subtitles.  The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs and exhibits shall, unless
otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 

5.9         Counterparts. 
This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute
such counterparts, and all of which together shall constitute one instrument.

 

5.10       Electronic
Execution and Delivery.  A facsimile, telecopy, pdf., email or other reproduction of this Agreement may be executed by
one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which
the signature of or on behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective
for all purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement
as well as any facsimile, telecopy, pdf. or other reproduction hereof.

 

5.11       Jurisdiction;
Venue.  Each of the parties hereto hereby submits and consents irrevocably to the exclusive jurisdiction of the courts
of the State of Delaware and the United States District Court for the District of Delaware for the interpretation and enforcement
of the provisions of this Agreement. Each of the parties hereto also agrees that the jurisdiction over the person of such parties
and the subject matter of such dispute shall be effected by the mailing of process or other papers in connection with any such
action in the manner provided for in Section 5.2 or in such other manner as may be lawful, and that service in such manner
shall constitute valid and sufficient service of process.

 

5.12       Further
Assurances.  Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability
company, partnership or other powers, all such other and additional instruments and documents and do all such other acts and things
as may be necessary to more fully effectuate this Agreement.

 

    	 	-20-	 

     

    

 

5.13       Termination
Upon Change of Control.  Notwithstanding anything to the contrary herein, this Agreement (excluding any then-existing
obligations) shall terminate upon (a) the acquisition of the Company by another entity by means of any transaction or series
of related transactions to which the Company is party (including, without limitation, any stock acquisition, reorganization, merger
or consolidation but excluding any sale of stock for capital raising purposes) other than a transaction or series of transactions
in which the holders of the voting securities of the Company outstanding immediately prior to such transaction continue to retain
(either by such voting securities remaining outstanding or by such voting securities being converted into voting securities of
the surviving entity), as a result of shares in the Company held by such holders prior to such transaction, at least fifty percent
(50%) of the total voting power represented by the voting securities of the Corporation or such surviving entity outstanding immediately
after such transaction or series of transactions; or (b) a sale, lease or other conveyance of all substantially all of the
assets of the Company.

 

5.14       Conflict. 
In the event of any conflict between the terms of this Agreement and the Company’s certificate of incorporation or its bylaws,
the terms of the Company’s certificate of incorporation or its bylaws, as the case may be, will control.

 

5.15       Attorneys’
Fees.  In the event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing party
in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such
prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys
and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

 

5.16       Aggregation
of Stock.  All securities held or acquired by affiliated entities (including affiliated venture capital funds) or persons
shall be aggregated together for purposes of determining the availability of any rights under this Agreement.

 

(signature page follows)

 

    	 	-21-	 

     

    

 

The parties are signing
this Amended and Restated Investors’ Rights Agreement as of the date stated in the introductory clause.

 

	 	EYENOVIA, INC.,
	 	a Delaware corporation
	 	 	 	 
	 	By:	/s/ Tsontcho Ianchulev
	 	 	Name:  	Tsontcho Ianchulev
	 	 	Title:	Chief Executive Officer

 

(Signature page to the Amended and Restated
Investors’ Rights Agreement)

 

     

     

    

 

The party below hereby
agrees, effective _________________, 2017, to become a party to this Amended and Restated Investors’ Rights Agreement and
for all purposes of this Amended and Restated Investors’ Rights Agreement the party below shall be included within the term
Investor.

 

	 	INVESTOR:
	 	 
	 	 
	 	(Print investor name)
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	 
	 	(Print title of signatory, if signing for an entity)

 

(Signature page to the Amended and Restated
Investors’ Rights Agreement)

 

     

     

    

 

Schedule 1

Series A Investors

 

	Name, Address and E-Mail

 

     

     

    

 

Schedule 2

Series A-2 Investors

 

	Name, Address and E-Mail

 

     

     

    

 

Schedule 3

Series B Investors

 

	Name, Address and E-Mail

 

     

     

    

 

EXHIBIT
A

 

NOTICE AND WAIVER/ELECTION OF

PRE-EMPTIVE RIGHTS

 

I do hereby waive or
exercise, as indicated below, my pre-emptive rights under the Amended and Restated Investors’ Rights Agreement dated as of
[_____________] (the “Agreement”):

 

1.          Waiver
of [___] days’ notice period in which to exercise right of first refusal: (please check only one)

 

		(   )	WAIVE
in full, on behalf of all Holders, the [___]-day notice period provided to exercise my pre-emptive rights granted under the
Agreement.

 

		(   )	DO
NOT WAIVE the notice period described above.

 

2.          Issuance
and Sale of New Securities: (please check only one)

 

		(   )	WAIVE
in full the pre-emptive rights granted under the Agreement with respect to the issuance of the New Securities.

 

		(   )	ELECT
TO PARTICIPATE in $__________ (please provide amount) in New Securities proposed to be issued by Eyenovia, Inc., a
Delaware corporation, representing LESS than my pro rata portion of the aggregate of $[_______] in New Securities being
offered in the financing.

 

		(   )	ELECT TO PARTICIPATE in $__________ in
New Securities proposed to be issued by Eyenovia, Inc., a Delaware corporation, representing my FULL pro rata portion of
the aggregate of $[_______] in New Securities being offered in the financing.

 

		(   )	ELECT TO PARTICIPATE in my full pro
rata portion of the aggregate of $[_______] in New Securities being made available in the financing AND, to the extent available,
the greater of (x) an additional $__________ (please provide amount) or (y) my pro rata portion of any
remaining investment amount available in the event other Significant Holders do not exercise their full pre-emptive rights with
respect to the $[_______] in New Securities being offered in the financing.

 

Date: ________________

 

	 	 
	 	(Print investor name)
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	 
	 	(Print title of signatory, if signing for an entity)

 

This is neither a commitment to purchase
nor a commitment to issue the New Securities described above. Such issuance can only be made by way of definitive documentation
related to such issuance. The company will supply you with such definitive documentation upon request or if you indicate that you
would like to exercise your first offer rights in whole or in part.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]